What is ANI Pharmaceuticals's EV / sales?

ANI Pharmaceuticals (ANIP) reported EV / sales of 1.9× in Q1 2026.

How has ANI Pharmaceuticals's EV / sales changed year-over-year?

ANI Pharmaceuticals's EV / sales decreased by 22.8% year-over-year, from 2.4× to 1.9×.

What is the long-term trend for ANI Pharmaceuticals's EV / sales?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's EV / sales has grown at a -8.4% compound annual growth rate (CAGR), from 3.2× to 2×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

ANI Pharmaceuticals ANIP EV / sales

EV / sales at other companies

Amneal Pharmaceuticals, Inc.AMRX

2.1×+0.4×

ViatrisVTRS

1.9×+0.3×

AnaptysBio, Inc.ANAB

5.8×+1.4×

ALN

Alnylam PharmaceuticalsALNY

9.9×-4.7×

Aurinia PharmaceuticalsAUPH

6.8×+2.2×

AmgenAMGN

6.6×+0.1×

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

enterprise value/total revenue=1.9×

Based on the most recent quarter.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's EV / sales?: ANI Pharmaceuticals (ANIP) reported EV / sales of 1.9× in Q1 2026.
How has ANI Pharmaceuticals's EV / sales changed year-over-year?: ANI Pharmaceuticals's EV / sales decreased by 22.8% year-over-year, from 2.4× to 1.9×.
What is the long-term trend for ANI Pharmaceuticals's EV / sales?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's EV / sales has grown at a -8.4% compound annual growth rate (CAGR), from 3.2× to 2×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.